Comparison of renal profile of the patients receiving Linagliptin or Vildagliptin in uncontrolled Type 2 Diabetes Mellitus
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2020/10/028572
- Lead Sponsor
- Burdwan Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Diagnosed cases of Type 2 Diabetes Mellitus
Both gender
Age more than equal to 18 years
Presence of any two of the following
HbA1c greater than or equal to 6.5
Fasting blood glucose greater than or equal to 126mg per dl
2 hour postprandial blood glucose greater than or equal to 200mg per dl
Patients under a stable dose of Metformin for previous 3 months before enrolment but not controlled
History of diabetic ketoacidosis or hyperosmolar state within last 3 months prior to enrolment
Patients with moderate to severe CKD
History of any major cardiac, CNS or gastrointestinal diseased)
Any uncontrolled major neuropsychiatric ailment
Any history of alcohol/substance abuse/dependence
History of acute / chronic pancreatitis
Diabetes secondary to pancreatic injury or other types of secondary diabetes
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in renal profile in patients receiving Linagliptin or VildagliptinTimepoint: at 2 months and at 6 months
- Secondary Outcome Measures
Name Time Method Change in glycemic indexTimepoint: At 2 months and 6 months